Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)?

State Street launched the SPDR S&P Pharmaceuticals ETF (XPH) on June 19, 2006. The passively managed ETF aims to provide broad equity-market exposure to the Healthcare—Pharma segment. The note is descriptive with no stated performance, flows, or policy change likely to move prices.

Analysis

State Street launched the SPDR S&P Pharmaceuticals ETF (XPH) on June 19, 2006. The passively managed ETF aims to provide broad equity-market exposure to the Healthcare—Pharma segment. The note is descriptive with no stated performance, flows, or policy change likely to move prices.